Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Skinvisible (SKVI) Notes Payables (2016 - 2025)

Skinvisible's Notes Payables history spans 14 years, with the latest figure at $352075.0 for Q4 2025.

  • On a quarterly basis, Notes Payables changed N/A to $352075.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $352075.0, a N/A change, with the full-year FY2025 number at $352075.0, changed N/A from a year prior.
  • Notes Payables hit $352075.0 in Q4 2025 for Skinvisible, roughly flat from $352075.0 in the prior quarter.
  • Over the last five years, Notes Payables for SKVI hit a ceiling of $2.8 million in Q3 2022 and a floor of $40000.0 in Q4 2022.
  • Historically, Notes Payables has averaged $1.0 million across 5 years, with a median of $376275.0 in 2024.
  • Biggest five-year swings in Notes Payables: soared 1658.77% in 2021 and later tumbled 98.59% in 2023.
  • Tracing SKVI's Notes Payables over 5 years: stood at $2.4 million in 2021, then plummeted by 98.32% to $40000.0 in 2022, then changed by 0.0% to $40000.0 in 2023, then skyrocketed by 904.4% to $401761.0 in 2024, then decreased by 12.37% to $352075.0 in 2025.
  • Business Quant data shows Notes Payables for SKVI at $352075.0 in Q4 2025, $352075.0 in Q3 2025, and $352075.0 in Q2 2025.